Sridhar Sneha B, Ferrara Assiamira, Brown Susan D, Quesenberry Charles P, Xu Fei, Liu Emily, Sedgwick Tali, Kissel Page, Serrato Bandera Hillary D, Albright Cheryl, Hedderson Monique M
Kaiser Permanente Northern California, Division of Research, Pleasanton, CA, United States of America.
Kaiser Permanente Northern California, Division of Research, Pleasanton, CA, United States of America; UPSTREAM - Center for Upstream Prevention of Adiposity and Diabetes Mellitus.
Contemp Clin Trials. 2025 Feb;149:107781. doi: 10.1016/j.cct.2024.107781. Epub 2024 Dec 20.
More than half of pregnant patients with overweight or obesity exceed national gestational weight gain (GWG) guidelines, increasing their risk of adverse outcomes. There is an urgent need to develop effective and scalable interventions to improve GWG.
To describe the protocol of Lifestyle, Eating, and Activity in Pregnancy (LEAP), a cluster randomized controlled trial evaluating a mobile health (mHealth) intervention promoting appropriate GWG in an integrated healthcare system.
LEAP is a cluster randomized trial with randomization at the clinician level. Patient eligibility includes a pre-pregnancy BMI of 25.0-40.0 kg/m and singleton pregnancy. Consented patients receive standard care or standard care plus mHealth intervention per their clinician's randomization. The patient adaptive intervention provides personalized, automated feedback on GWG and physical activity using 1) a smartphone application, 2) a Wi-Fi scale and activity tracker; 3) weekly educational topics; and 4) step-wise support (added when GWG is >75th percentile of the GWG guidelines). Intervention clinicians receive newsletters with motivational interviewing tips to facilitate discussing GWG. Primary outcomes are total GWG (last measured weight - pre-pregnancy weight) and weekly rate of GWG (total GWG/gestational weeks at delivery) as continuous variables and categorized per the IOM GWG guidelines. Secondary outcomes include trimester-specific rate of GWG, GWG trajectory, diet and physical activity, postpartum weight retention, birthweight, infant size for gestational age, and infant growth to 12 months.
LEAP addresses gaps in the implementation of GWG interventions in healthcare settings. The adaptive and mHealth nature of the intervention may enhance scalability.
ClinicalTrials.govNCT03880461.
超过半数超重或肥胖的孕妇超过了国家孕期体重增加(GWG)指南的标准,这增加了她们出现不良结局的风险。迫切需要制定有效且可扩展的干预措施来改善孕期体重增加情况。
描述孕期生活方式、饮食与活动(LEAP)试验方案,这是一项整群随机对照试验,评估在综合医疗系统中促进适当孕期体重增加的移动健康(mHealth)干预措施。
LEAP是一项在临床医生层面进行随机分组的整群随机试验。患者入选标准包括孕前体重指数(BMI)为25.0 - 40.0kg/m²且为单胎妊娠。同意参与的患者根据其临床医生的随机分组接受标准护理或标准护理加移动健康干预。患者适应性干预通过以下方式提供关于孕期体重增加和身体活动的个性化、自动化反馈:1)智能手机应用程序;2)Wi-Fi体重秤和活动追踪器;3)每周教育主题;4)逐步支持(当孕期体重增加超过GWG指南的第75百分位数时增加)。干预临床医生会收到包含动机性访谈技巧的时事通讯,以促进关于孕期体重增加的讨论。主要结局为孕期体重增加总量(末次测量体重 - 孕前体重)和每周孕期体重增加率(孕期体重增加总量/分娩时孕周),作为连续变量,并根据美国医学研究所(IOM)的GWG指南进行分类。次要结局包括各孕期的孕期体重增加率、孕期体重增加轨迹、饮食和身体活动、产后体重滞留、出生体重、胎儿出生时的孕周别大小以及婴儿12个月时的生长情况。
LEAP解决了医疗环境中孕期体重增加干预措施实施方面的差距。该干预措施的适应性和移动健康性质可能会提高其可扩展性。
ClinicalTrials.govNCT03880461。